ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,69
0,00%
Dow Jones
43 325,80
0,07%
DAX
19 838,48
0,00%
Brent Oil
72,995
0,14%
Bitcoin
95 646,99
-0,04%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSX

  6. Resverlogix Corp (RVX) Cours

Resverlogix Corp

Resverlogix Corp (RVX)

TSX
0,055
0,00
(0,00%)
Fermé 27 Décembre 10:12PM
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
0,055
Prix Achat
0,05
Prix Vente
0,055
Volume échangé
248 000
0,05 Fourchette du Jour 0,055
0,04 Plage de 52 semaines 0,095
Cap du marché
14,98M
Clôture Veille
0,055
Ouverture
0,055
Dernière Transaction
1000
@
0.055
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
60 809
Actions en circulation
272 371 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,81
Bénéfice par action (BPA)
-0,06
Chiffre d'affairess
57k
Bénéfice net
-16,74M

À propos de Resverlogix Corp

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.resverlogix.com
Siège social
Calgary, Alberta, Can
Fondé
-
Resverlogix Corp est coté dans le secteur Biological Pds,ex Diagnstics de la Toronto Stock Exchange avec le ticker RVX. Le dernier cours de clôture d'Resverlogix était de $0,06. Au cours de la dernière année, les actions de Resverlogix ont été négociées dans une fourchette de prix de $ 0,04 à $ 0,095.

Resverlogix compte actuellement 272 371 000 actions en circulation. La capitalisation boursière d'Resverlogix est de $14,98 million. Resverlogix a un ratio cours/bénéfice (ratio PE) de -0.81.

RVX Dernières nouvelles

Plus de nouvelles

InvestmentPitch Media Video Discusses Resverlogix and its Focus on Apabetalone’s Future Development for the Prevention and Treatment of Post COVID-19 Conditions

VANCOUVER, British Columbia, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. (TSX:RVX) (OTCPink:RVXCF), a world leader in epigenetics, or gene regulation, announced that apabetalone’s...

30 Septembre 2022
GlobeNewswire Inc.

Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions

CALGARY, Alberta, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the “Company”) (TSX:RVX) today announced that apabetalone’s future clinical development related to...

28 Septembre 2022
GlobeNewswire Inc.

Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease

CALGARY, Alberta, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the publication of an article entitled “Reduction in the Risk of Major Adverse...

22 Août 2022
GlobeNewswire Inc.

Resverlogix Announces Appointment of New Chief Scientific Officer

CALGARY, Alberta, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the appointment of Dr. Ewelina Kulikowski, Ph.D. as Chief Scientific Officer. Dr...

16 Août 2022
GlobeNewswire Inc.

Resverlogix Announces Voting Results from the 2022 Meeting of Shareholders

CALGARY, Alberta, June 21, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix”, or the "Corporation") (TSX:RVX) today held its Annual Meeting of Shareholders (the “Meeting”) in Calgary...

22 Juin 2022
GlobeNewswire Inc.

Resverlogix Announces New Research Findings Highlighting the Safety of BD2-selective BET Inhibitors

CALGARY, Alberta, June 08, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the publication of an article entitled “Breaking boundaries: Pan BETi disrupt 3D...

08 Juin 2022
GlobeNewswire Inc.

Resverlogix Announces Type C Meeting with FDA for CORAL, a Phase 3 High-risk COVID-19 Outpatient Study

CALGARY, Alberta, May 09, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix", or "the Company") (TSX:RVX), in partnership with EVERSANA™, today announced that the U.S. Food and Drug...

09 Mai 2022
GlobeNewswire Inc.

Resverlogix Announces One-Year Extension of Debenture

CALGARY, Alberta, April 19, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the “Company”) (TSX:RVX) announced today that it has closed a one-year extension of Company’s US$6.0...

19 Avril 2022
GlobeNewswire Inc.

Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine

CALGARY, Alberta, March 17, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the publication of an article entitled “BET Protein Inhibition for Pulmonary...

17 Mars 2022
GlobeNewswire Inc.

Resverlogix Corp. to Webcast Live at VirtualInvestorConferences.com March 10th

CALGARY, Alberta, March 09, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX), a global leader in the development of epigenetic therapeutics, today announced that Donald...

09 Mars 2022
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1000.0550.060.05813880.055CS
4-0.005-8.333333333330.060.060.05882840.05681243CS
120.005100.050.0650.05608090.05905778CS
260.005100.050.0950.04818970.06806775CS
52-0.015-21.42857142860.070.0950.04585430.0662825CS
156-0.515-90.3508771930.570.820.04682800.17445797CS
260-1.145-95.41666666671.21.530.04650280.44140476CS

RVX - Frequently Asked Questions (FAQ)

What is the current Resverlogix share price?
The current share price of Resverlogix is $ 0,055
How many Resverlogix shares are in issue?
Resverlogix has 272 371 000 shares in issue
What is the market cap of Resverlogix?
The market capitalisation of Resverlogix is CAD 14,98M
What is the 1 year trading range for Resverlogix share price?
Resverlogix has traded in the range of $ 0,04 to $ 0,095 during the past year
What is the PE ratio of Resverlogix?
The price to earnings ratio of Resverlogix is -0,81
What is the cash to sales ratio of Resverlogix?
The cash to sales ratio of Resverlogix is 250
What is the reporting currency for Resverlogix?
Resverlogix reports financial results in USD
What is the latest annual turnover for Resverlogix?
The latest annual turnover of Resverlogix is USD 57k
What is the latest annual profit for Resverlogix?
The latest annual profit of Resverlogix is USD -16,74M
What is the registered address of Resverlogix?
The registered address for Resverlogix is 4820 RICHARD ROAD S.W, SUITE 300, CALGARY, ALBERTA, T3E 6L1
What is the Resverlogix website address?
The website address for Resverlogix is www.resverlogix.com
Which industry sector does Resverlogix operate in?
Resverlogix operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
GMTNGold Mountain Mining Corp
$ 0,035
(16,67%)
10k
XLYAuxly Cannabis Group Inc
$ 0,035
(16,67%)
378,93k
PPRPrairie Provident Resources Inc
$ 0,035
(16,67%)
390k
WRXWestern Resources Corp
$ 0,04
(14,29%)
3k
GFRGreenfire Resources Ltd
$ 10,09
(13,37%)
31,9k
RTGRTG Mining Inc
$ 0,025
(-37,50%)
100k
NCFNorthcliff Resources Ltd
$ 0,02
(-20,00%)
1,03M
KLSKelso Technologies Inc
$ 0,11
(-15,38%)
3,5k
AVLAvalon Advanced Materials Inc
$ 0,035
(-12,50%)
114k
YRBYorbeau Resources Inc
$ 0,035
(-12,50%)
110k
TTelus Corp
$ 19,45
(-1,52%)
4,87M
BBBlackBerry Limited
$ 5,65
(4,05%)
3,61M
ABXBarrick Gold Corporation
$ 22,55
(0,71%)
3,57M
BITFBitfarms Ltd
$ 2,45
(6,06%)
3,26M
FCUFission Uranium Corp
$ 0,72
(-2,70%)
2,54M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

TSX
RVX
Resverlogix
BIT
S28939
Societe Generale Effekten
BOV
CAPH34
Capri
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés